Renaissance Technologies’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Renaissance Technologies’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-86,887	Closed	-$143K	–	4712
2022 Q1	$143K	Buy	86,887 +47,513	+121%	+$84.8K	﹤0.01%	3725
2021 Q4	$94K	Buy	39,374 +9,574	+32%	+$39K	﹤0.01%	3693
2021 Q3	$163K	Buy	+29,800	New	+$185K	﹤0.01%	3248
2021 Q2	–	Sell	-54,100	Closed	-$438K	–	3905
2021 Q1	$438K	Buy	+54,100	New	+$589K	﹤0.01%	2956

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies's KLDO Position: Q2 2022 in Review

Renaissance Technologies sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 86,887 shares — an estimated $143K sold.

Renaissance Technologies first reported a position in KLDO in Q1 2021 and held it in 4 quarters. The position peaked at $438K in Q1 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Renaissance Technologies reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Renaissance Technologies sold 86,887 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $143K.
Renaissance Technologies first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Renaissance Technologies's Kaleido Biosciences, Inc. Common Stock position peaked at $438K in Q1 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.